107 related articles for article (PubMed ID: 27466500)
1. Evaluation of Global Histone Acetylation Levels in Bladder Cancer Patients.
Ellinger J; Schneider AC; Bachmann A; Kristiansen G; Müller SC; Rogenhofer S
Anticancer Res; 2016 Aug; 36(8):3961-4. PubMed ID: 27466500
[TBL] [Abstract][Full Text] [Related]
2. Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer.
Ellinger J; Bachmann A; Göke F; Behbahani TE; Baumann C; Heukamp LC; Rogenhofer S; Müller SC
Urol Int; 2014; 93(1):113-8. PubMed ID: 24556868
[TBL] [Abstract][Full Text] [Related]
3. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma.
Mosashvilli D; Kahl P; Mertens C; Holzapfel S; Rogenhofer S; Hauser S; Büttner R; Von Ruecker A; Müller SC; Ellinger J
Cancer Sci; 2010 Dec; 101(12):2664-9. PubMed ID: 20825416
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
Damodaran S; Damaschke N; Gawdzik J; Yang B; Shi C; Allen GO; Huang W; Denu J; Jarrard D
BMC Cancer; 2017 Dec; 17(1):874. PubMed ID: 29262808
[TBL] [Abstract][Full Text] [Related]
5. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
[TBL] [Abstract][Full Text] [Related]
6. Global levels of histone modifications predict prostate cancer recurrence.
Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
[TBL] [Abstract][Full Text] [Related]
7. Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer.
Schneider AC; Heukamp LC; Rogenhofer S; Fechner G; Bastian PJ; von Ruecker A; Müller SC; Ellinger J
BJU Int; 2011 Oct; 108(8 Pt 2):E290-6. PubMed ID: 21627749
[TBL] [Abstract][Full Text] [Related]
8. Global histone modification patterns predict risk of prostate cancer recurrence.
Seligson DB; Horvath S; Shi T; Yu H; Tze S; Grunstein M; Kurdistani SK
Nature; 2005 Jun; 435(7046):1262-6. PubMed ID: 15988529
[TBL] [Abstract][Full Text] [Related]
9. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
[TBL] [Abstract][Full Text] [Related]
10. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
11. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
[TBL] [Abstract][Full Text] [Related]
12. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
[TBL] [Abstract][Full Text] [Related]
13. Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease.
Kocic G; Cukuranovic J; Stoimenov TJ; Cukuranovic R; Djordjevic V; Bogdanovic D; Stefanovic V
Ren Fail; 2014 Aug; 36(7):1078-82. PubMed ID: 24845033
[TBL] [Abstract][Full Text] [Related]
14. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
Denzinger S; Stoehr R; Schwarz S; Eichenseher N; Brockhoff G; Obermann EC; Knuechel R; Blaszyk H; Hartmann A; Wild PJ
Int J Oncol; 2007 Oct; 31(4):793-802. PubMed ID: 17786310
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential.
Barbisan F; Mazzucchelli R; Santinelli A; Stramazzotti D; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
Int J Immunopathol Pharmacol; 2008; 21(3):615-23. PubMed ID: 18831929
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.
Hofner T; Macher-Goeppinger S; Klein C; Schillert A; Eisen C; Wagner S; Rigo-Watermeier T; Baccelli I; Vogel V; Trumpp A; Sprick MR
Urol Oncol; 2014 Jul; 32(5):678-86. PubMed ID: 24631171
[TBL] [Abstract][Full Text] [Related]
17. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
[TBL] [Abstract][Full Text] [Related]
18. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
19. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
Song JS; Kim YS; Kim DK; Park SI; Jang SJ
Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
[TBL] [Abstract][Full Text] [Related]
20. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Elsheikh SE; Green AR; Rakha EA; Powe DG; Ahmed RA; Collins HM; Soria D; Garibaldi JM; Paish CE; Ammar AA; Grainge MJ; Ball GR; Abdelghany MK; Martinez-Pomares L; Heery DM; Ellis IO
Cancer Res; 2009 May; 69(9):3802-9. PubMed ID: 19366799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
